The effect of simvastatin on progression of coronary artery disease: The Multicenter Coronary Intervention Study (CIS)

Abstract

Treatment with 40 mg simvastatin day-1 reduces serum cholesterol and slows the progression of coronary artery disease significantly within a short period of treatment time. In the treatment group, retardation of progression is inversely correlated to the LDL-cholesterol levels achieved.